Home › NDC Lookup › RxCUI directory › RxCUI 2638691

Sotagliflozin 400 MG Oral Tablet — RxCUI 2638691

Name: Sotagliflozin 400 MG Oral Tablet (RxCUI 2638691)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2638691 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2638691

Official nameSotagliflozin 400 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped3

Package NDCs mapped6

Reported Medicaid activity (SDUD)830 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Sotagliflozin 400 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Sotagliflozin 400 MG Oral Tablet RxCUI 2638691 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Sotagliflozin 2638675 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Inpefa 2638684 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Sotagliflozin Oral Tablet 2638682 SCDF
- Sotagliflozin Oral Product 2638680 SCDG
- Sotagliflozin Pill 2638681 SCDG
- Sotagliflozin Oral Tablet [Inpefa] 2638688 SBDF
- Inpefa Oral Product 2638686 SBDG
- Inpefa Pill 2638687 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Sotagliflozin 400 MG 2638690 SCDC
- Sotagliflozin 400 MG Oral Tablet [Inpefa] 2638693 SBD
- Sotagliflozin 400 MG [Inpefa] 2638692 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Sotagliflozin 400 MG SCDC · 2638690
Sotagliflozin Oral Tablet SCDF · 2638682
Sotagliflozin Oral Product SCDG · 2638680
Sotagliflozin Pill SCDG · 2638681

Brand-Name Concepts

Sotagliflozin 400 MG Oral Tablet [Inpefa] SBD · 2638693
Sotagliflozin 400 MG [Inpefa] SBDC · 2638692
Sotagliflozin Oral Tablet [Inpefa] SBDF · 2638688
Inpefa Oral Product SBDG · 2638686
Inpefa Pill SBDG · 2638687
Inpefa BN · 2638684

📦 FDA Products & Package NDCs

3 products · 6 package NDCs

6 package NDCs map to RxCUI 2638691 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
70183-0220-07	1 BLISTER PACK in 1 CARTON (70183-220-07) / 7 TABLET in 1 B...	INPEFA	Lexicon Pharmaceuticals, Inc.	2023-05-26
70183-0220-30	30 TABLET in 1 BOTTLE (70183-220-30)	INPEFA	Lexicon Pharmaceuticals, Inc.	2023-05-26
70183-0221-07	1 BLISTER PACK in 1 CARTON (70183-221-07) / 7 TABLET in 1 B...	INPEFA	Lexicon Pharmaceuticals, Inc.	2024-01-15
70183-0221-30	30 TABLET in 1 BOTTLE (70183-221-30)	INPEFA	Lexicon Pharmaceuticals, Inc.	2024-03-01
70183-0221-31	1 BLISTER PACK in 1 CARTON (70183-221-31) / 3 BLISTER PACK...	INPEFA	Lexicon Pharmaceuticals, Inc.	2023-12-01
70183-0241-30	30 TABLET in 1 BOTTLE (70183-241-30)	INPEFA	Lexicon Pharmaceuticals, Inc.	2023-12-01

Observed labelers: Lexicon Pharmaceuticals, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.